Product Description

Known For: Nebraska’s highest-rated interventional pain practice offering IV ketamine — 4.85/5 stars across 766 reviews — specifically equipped for patients with complex pain conditions like CRPS, phantom limb pain, and cancer-induced neuropathic pain alongside depression and PTSD.

HealingMaps Take: Nebraska Pain Institute’s IV ketamine program is differentiated by two things: the pain-management clinical expertise of the prescribing physicians, and the 4.85/5 star rating across 766 patient reviews — an extraordinarily high volume of validated feedback for a specialty medical practice. The 4-hour infusion duration is notably longer than typical psychiatric ketamine protocols (40-60 minutes), which reflects pain-management dosing: longer infusions are often more effective for chronic pain conditions than the shorter protocols optimized for depression. The ability to treat CRPS, phantom limb pain, post-herpetic neuralgia, fibromyalgia, and cancer-induced neuropathic pain alongside depression and PTSD positions the practice for patients whose mental health symptoms are intertwined with physical pain — a common presentation that pure psychiatric ketamine clinics are often not equipped to address comprehensively. Multiple MD clinicians (Drs. Whitten, Spurgeon, and Reilly) plus PAs and APRNs provide clinical depth and scheduling flexibility. The southeast Lincoln Willowbrook Lane location serves southern Lincoln and the Beatrice/Crete/Seward corridor. For Nebraska patients whose depression or PTSD is tangled with chronic pain conditions — especially complex neuropathic or regional pain syndromes — Nebraska Pain Institute offers genuinely specialized clinical expertise that purely psychiatric ketamine providers cannot match.

Patient Review

“Nebraska Pain Institute’s CRPS expertise was the reason I chose them over a straight psychiatric ketamine clinic. My depression was rooted in six years of CRPS pain, and the doctors understood that treating one without the other would just yield partial results. The 4-hour infusion was longer than I expected but clearly calibrated for complex pain, not just mood.”

About Nebraska Pain Institute

Nebraska Pain Institute is a leading interventional pain management practice at 7350 Willowbrook Lane, Lincoln, NE 68516. The practice provides IV ketamine infusion therapy alongside comprehensive interventional pain management, with physicians Dr. C. Weston Whitten, MD; Dr. Douglas Spurgeon, MD; and Dr. Austin Reilly, MD leading clinical care with support from multiple PAs and APRNs. Ketamine infusions are approximately 4 hours in duration and treat Complex Regional Pain Syndrome, spinal cord injury, phantom limb pain, post-herpetic neuralgia, fibromyalgia, cancer-induced neuropathic pain, depression, and PTSD. The practice holds a 4.85/5 star rating across 766 patient reviews.

For more on how ketamine therapy works, see our complete guide to ketamine therapy.

What People Like

4.85/5 stars across 766 patient reviews — highest-rated Nebraska pain practice. Three MD clinicians plus PA and APRN team for clinical depth. Pain-management-calibrated 4-hour infusion protocols (longer than standard psychiatric dosing). Specialized clinical expertise for CRPS, phantom limb pain, cancer neuropathy. Treats depression and PTSD alongside complex pain conditions.

What People Don’t Like

Self-pay for ketamine typical. No Spravato option. No formal KAP model. 4-hour infusion requires substantial appointment commitment. Pain management branding may not appeal to patients seeking purely psychiatric care. Willowbrook Lane location less convenient for northwest Lincoln patients.

Getting Started at Nebraska Pain Institute

Call (402) 488-7246 or visit nebraskapaininstitute.com/services/ketamine-infusions. Located at 7350 Willowbrook Lane, Lincoln, NE 68516. Initial consultation determines candidacy for ketamine infusion — the practice particularly excels with patients whose depression or PTSD is entangled with chronic pain.

Learn more about the evidence behind ketamine for depression at the National Institute of Mental Health.